Myers, R B <br/><br/>
Elevated serum levels of p105(erbB-2) in patients with advanced-stage prostatic adenocarcinoma.  [electronic resource] 

 -  International journal of cancer  Oct 1996 
 - 398-402 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0020-7136 
<br/><br/><label>Standard No.: </label>10.1002/(SICI)1097-0215(19961021)69:5<398::AID-IJC8>3.0.CO;2-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--immunology<br/>Enzyme-Linked Immunosorbent Assay<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>NF-kappa B--blood<br/>NF-kappa B p50 Subunit<br/>Prostate-Specific Antigen--analysis<br/>Prostatic Diseases--immunology<br/>Prostatic Hyperplasia--immunology<br/>Prostatic Neoplasms--immunology<br/>Protein Precursors--blood<br/>Receptor, ErbB-2--blood